Phase I/II Study of the Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Trial Profile

Phase I/II Study of the Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Completed
Phase of Trial: Phase I/II

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs Adult neural stem cells (Primary)
  • Indications Dry age-related macular degeneration
  • Focus Adverse reactions
  • Sponsors StemCells
  • Most Recent Events

    • 09 Jul 2015 Status changed from active, no longer recruiting to completed, as reported in StemCells media release.
    • 26 Jun 2015 According to StemCells media release, data from this trial has been presented at the 2015 Annual Meeting of the International Society for Stem Cell Research (ISSCR).
    • 26 Jun 2015 Top-line results published in StemCells Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top